It's an incredibly exciting time to be in precision oncology - for our company, the physicians we work with and most importantly, the patients they treat. We are extremely proud of all the work this team has done to keep moving us forward. The future looks bright! Ignite Proteomics Faith Zaslavsky Emanuel Petricoin Justin Davis Claudius Mueller Brian Corgiat Kayla Sparks, PhD Emily Fogarty, PhD Chris Arnell Michael Vallone Katie Schultz Mattia Cremona https://lnkd.in/eaB5X--M
About us
IMAC Holdings was founded in 2015 to manage outpatient medical clinics focused on conservative orthopedic therapies to optimize a person's movement without surgery. IMAC completed an initial public offering on Nasdaq in February, 2019.
- Industry
- Hospitals and Health Care
- Company size
- 2-10 employees
- Type
- Public Company
- Founded
- 2015
Employees at IMAC Holdings
Updates
-
As IMAC Holdings begins to focus on their proteomic business in oncology, we are excited to announce the appointment of Peter Beitsch MD and Matthew Schwartz, MD to our board of directors. Faith Zaslavsky, President and CEO of IMAC, shared ""We are thrilled to welcome Dr. Peter Beitsch and Dr. Matthew Schwartz to our Board of Directors," said Faith Zaslavsky, President and CEO at IMAC. "Their combined expertise and vision will be instrumental in steering the Company towards new heights of innovation and success in the field of proteomics." https://lnkd.in/evgSJM-W
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors | IMAC Holdings, Inc.
imacregeneration.gcs-web.com